Search alternatives:
point decrease » point increase (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
-
1
-
2
-
3
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”
-
4
-
5
-
6
Decreased cell stiffness after dissociation of intercellular adhesion.
Published 2014“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”
-
7
-
8
Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro.
Published 2009“…<p>(A) In order to avoid overlap of the heavy chain signal (∼50 kDa) with the βIII-tubulin signal (∼55 kDa) in the immunoprecipitation using the Capzb2 monoclonal antibody (mAb), the antibody was coupled to the protein G/A beads through cross-linking. βIII-tubulin and Capzb2 signals were each detected following immunoprecipitation from brain lysate with both βIII-tubulin rabbit antibody (rAb)-coupled beads and Capzb2 mAb-coupled beads. …”
-
9
-
10
-
11
-
12
<i>roh</i> mutation results in Rh1 decrease.
Published 2015“…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
-
13
-
14
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
15
-
16
-
17
-
18
-
19
-
20